Concepedia

p38 MAPK inhibition enhances PS-341 (bortezomib)-induced cytotoxicity against multiple myeloma cells

Teru Hideshima, Klaus Podar, Dharminder Chauhan, Kenji Ishitsuka, Constantine Mitsiades, Yu‐Tzu Tai, Makoto Hamasaki, Noopur Raje, Hiromasa Hideshima, George F. Schreiner,

Oncogene · 2004 · 132 citations · 32 references

DOI

Concepts

References

32

A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma

Paul G. Richardson, Bart Barlogie, James R. Berenson et al. · New England Journal of Medicine · 2003 · 2.6K citations · Full text

, , +10

DNA Damage-Induced Phosphorylation of p53 Alleviates Inhibition by MDM2

Sheau-Yann Shieh, Masako Ikeda, Yoichi Taya et al. · Cell · 1997 · 2.1K citations · Full text

, , +13

Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells

Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro et al. · Immunity · 1999 · 1.7K citations · Full text

, , +16

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

Nicholas Mitsiades, Constantine Mitsiades, Vassiliki Poulaki et al. · Proceedings of the National Academy of Sciences · 2002 · 748 citations · Full text

, , +16

The proteasome inhibitor PS-341 potentiates sensitivity of multiple myeloma cells to conventional chemotherapeutic agents: therapeutic applications

Nicholas Mitsiades, Constantine S. Mitsiades, Paul G. Richardson et al. · Blood · 2003 · 702 citations

, , +14